MET · Metlife Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $77.08B | $70.99B | $66.91B | $69.90B | $71.08B | $67.84B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $560.00M | $481.00M | $828.00M | $700.00M | $686.00M | $761.00M |
| Total Operating Expenses | $13.86B | $13.02B | $12.71B | $12.03B | $12.59B | $13.15B |
| D&A | $117.00M | $124.00M | $112.00M | $171.00M | $192.00M | $194.00M |
| Operating Income | $6.14B | $6.00B | $2.16B | $2.86B | $8.13B | $6.93B |
| Interest Expense | $724.00M | $738.00M | $740.00M | $655.00M | $647.00M | $632.00M |
| Income Tax | $1.26B | $1.18B | $560.00M | $301.00M | $1.55B | $1.51B |
| Net Income | $3.38B | $4.43B | $1.58B | $2.54B | $6.55B | $5.41B |
| EPS - Basic | $4.74 | $5.98 | $1.82 | $2.93 | $7.36 | $5.72 |
| EPS - Diluted | $4.71 | $5.94 | $1.81 | $2.91 | $7.31 | $5.68 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $22.03B | $20.07B | $20.64B | $20.20B | $20.05B | $19.80B |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $745.17B | $677.46B | $687.58B | $666.61B | $759.71B | $795.15B |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $716.25B | $649.75B | $657.33B | $639.32B | $691.96B | $720.33B |
| Stockholders' Equity | $28.40B | $27.45B | $30.02B | $27.04B | $67.48B | $74.56B |
| Retained Earnings | $44.29B | $42.63B | $40.15B | $41.95B | $41.20B | $36.49B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $17.09B | $14.60B | $13.72B | $13.20B | $12.60B | $11.64B |
| Investing Cash Flow | ($15.61B) | ($11.49B) | ($10.25B) | ($2.62B) | ($11.19B) | ($18.57B) |
| Financing Cash Flow | $163.00M | ($3.13B) | ($2.94B) | ($10.11B) | ($1.38B) | $10.73B |
| CapEx | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | 8.0% | 8.4% | 3.2% | 4.1% | 11.4% | 10.2% |
| EBITDA margin | 8.1% | 8.6% | 3.4% | 4.3% | 11.7% | 10.5% |
| Net margin | 4.4% | 6.2% | 2.4% | 3.6% | 9.2% | 8.0% |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 0.7% | 0.7% | 1.2% | 1.0% | 1.0% | 1.1% |
| Effective tax rate | 27.1% | 21.0% | 26.2% | 10.6% | 19.1% | 21.8% |
| Return on assets | 0.5% | 0.7% | 0.2% | 0.4% | 0.9% | 0.7% |
| Return on equity | 11.9% | 16.1% | 5.3% | 9.4% | 9.7% | 7.3% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | 8.5x | 8.1x | 2.9x | 4.4x | 12.6x | 11.0x |
| Equity multiplier | 26.24 | 24.68 | 22.91 | 24.65 | 11.26 | 10.66 |
| Liabilities / Assets | 0.96 | 0.96 | 0.96 | 0.96 | 0.91 | 0.91 |
| Efficiency | ||||||
| Asset turnover | 0.10 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 16.8x | 13.8x | 36.5x | 24.9x | 8.5x | 8.3x |
| P / B | 1.9x | 2.1x | 1.7x | 2.2x | 0.8x | 0.6x |
| P / S | 0.7x | 0.8x | 0.8x | 0.8x | 0.8x | 0.6x |
| EV / EBITDA | 5.0x | 6.2x | 13.1x | 12.7x | 4.1x | 3.2x |
| Growth | ||||||
| Revenue growth (YoY) | 8.6% | 6.1% | -4.3% | -1.7% | 4.8% | -2.6% |
| Revenue CAGR (3y) | 3.3% | -0.0% | -0.5% | 0.1% | 1.5% | 2.9% |
| Revenue CAGR (5y) | 2.6% | 0.4% | -0.3% | 2.3% | 2.3% | -0.6% |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | 2.4% | 177.3% | -24.4% | -64.8% | 17.3% | 1.9% |
| Net income growth (YoY) | -23.7% | 180.5% | -37.8% | -61.3% | 21.2% | -8.3% |
| EPS growth (YoY) | -20.7% | 228.2% | -37.8% | -60.2% | 28.7% | -6.3% |
| EPS CAGR (3y) | 17.4% | -6.7% | -31.7% | -21.7% | 14.2% | 16.2% |
| EPS CAGR (5y) | -3.7% | -0.4% | -18.1% | -4.3% | 63.3% | 4.4% |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 3.5% | -8.6% | 11.0% | -59.9% | -9.5% | 12.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$72.27B totalGroup Benefits Segment$26.88B · 37.2%
Retirement And Income Solutions Segment$21.04B · 29.1%
Asia Segment$11.96B · 16.5%
Latin America Segment$8.30B · 11.5%
EMEASegment$3.15B · 4.4%
Met Life Investment Management Segment$938.00M · 1.3%
Product / service
$2.44B totalPrepaidlegalplansandadministrativeonlycontracts$637.00M · 26.1%
Vision Fee For Service Arrangements$561.00M · 23.0%
Otherrevenuefromservicecontractsfromcustomers$432.00M · 17.7%
Feebasedinvestmentmanagementservices$369.00M · 15.1%
Administrative Service$295.00M · 12.1%
Distribution Service$142.00M · 5.8%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
4/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- -Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Life Insurance
Comparing METLIFE INC against the 5 most active filers in the same SIC group.
Dividends
$2.30/share trailing 12 months · +4.3% YoY
| Ex-date | Per share |
|---|---|
| May 12, 2026 | $0.5930 |
| Feb 3, 2026 | $0.5680 |
| Nov 4, 2025 | $0.5680 |
| Aug 5, 2025 | $0.5680 |
| May 6, 2025 | $0.5680 |
| Feb 4, 2025 | $0.5450 |
| Nov 5, 2024 | $0.5450 |
| Aug 6, 2024 | $0.5450 |
| May 6, 2024 | $0.5450 |
| Feb 5, 2024 | $0.5200 |
| Nov 8, 2023 | $0.5200 |
| Aug 7, 2023 | $0.5200 |
| May 8, 2023 | $0.5200 |
| Feb 6, 2023 | $0.5000 |
| Nov 7, 2022 | $0.5000 |
| Aug 8, 2022 | $0.5000 |
| May 9, 2022 | $0.5000 |
| Feb 7, 2022 | $0.4800 |
| Nov 8, 2021 | $0.4800 |
| Aug 9, 2021 | $0.4800 |
| May 10, 2021 | $0.4800 |
| Feb 4, 2021 | $0.4600 |
| Nov 2, 2020 | $0.4600 |
| Aug 3, 2020 | $0.4600 |